Laura Galli
- Virology top 0.5%
- HIV Research and Treatment 96
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 92
- HIV/AIDS Research and Interventions 57
- Emergency Medicine top 1%
- HIV-related health complications and treatments 42
- Internal Medicine top 2%
- Hepatology top 5%
- Hepatitis C virus research 25
-
- Pneumocystis jirovecii pneumonia detection and treatment 14
- Liver Disease Diagnosis and Treatment 12
-
- Urinary Bladder and Prostate Research 10
- Co-authors
- Adriano LazzarinAntonella CastagnaNicola GianottiAntonio E. PontiroliKarl C. PodratzArmando D’AngeloMaurice J. WebbAndrea Mariani
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Laura Galli
284 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 152
- Virology 948
- Infectious Diseases 1.3k
- Emergency Medicine 508
- Internal Medicine 187
- Hepatology 267
Countries citing papers authored by Laura Galli
This map shows the geographic impact of Laura Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Galli more than expected).
Fields of papers citing papers by Laura Galli
This network shows the impact of papers produced by Laura Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Galli. The network helps show where Laura Galli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Galli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 6 | |
| 13 | Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat. | 2018 | 9 |
| 14 | 2010 | 37 | |
| 15 | Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy. | 2007 | 6 |
| 16 | 2006 | 15 | |
| 17 | Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a. | 2004 | 9 |
| 18 | Psoriatic arthritis in British and Italian patients: a comparative clinical, radiologic, and scintigraphic study. | 1999 | 5 |
| 19 | The preservation of the ocular surface during chronic administration of hypotensive eye drops | 1997 | 1 |
| 20 | 1997 | 65 |
About Laura Galli
Laura Galli is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 298 papers that have together received 5.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (96 papers), HIV/AIDS drug development and treatment (92 papers), HIV/AIDS Research and Interventions (57 papers), HIV-related health complications and treatments (42 papers), Hepatitis C virus research (25 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Urinary Bladder and Prostate Research (10 papers). The work is most often cited by research in Virology (948 citations), Infectious Diseases (1.3k citations) and Emergency Medicine (508 citations). Laura Galli has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Adriano Lazzarin, Antonella Castagna, Nicola Gianotti, Antonio E. Pontiroli, Karl C. Podratz, Armando D’Angelo, Maurice J. Webb, Andrea Mariani, Ferruccio Fazio and Paolo Rama. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.